Cargando…
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012553/ https://www.ncbi.nlm.nih.gov/pubmed/36918897 http://dx.doi.org/10.1186/s13023-023-02647-z |
| _version_ | 1784906626669477888 |
|---|---|
| author | Diaz, George A. Giugliani, Roberto Gufon, Nathalie Jones, Simon A. Mengel, Eugen Scarpa, Maurizio Witters, Peter Yarramaneni, Abhimanyu Li, Jing Armstrong, Nicole M. Kim, Yong Ortemann-Renon, Catherine Kumar, Monica |
| author_facet | Diaz, George A. Giugliani, Roberto Gufon, Nathalie Jones, Simon A. Mengel, Eugen Scarpa, Maurizio Witters, Peter Yarramaneni, Abhimanyu Li, Jing Armstrong, Nicole M. Kim, Yong Ortemann-Renon, Catherine Kumar, Monica |
| author_sort | Diaz, George A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10012553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100125532023-03-15 Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results Diaz, George A. Giugliani, Roberto Gufon, Nathalie Jones, Simon A. Mengel, Eugen Scarpa, Maurizio Witters, Peter Yarramaneni, Abhimanyu Li, Jing Armstrong, Nicole M. Kim, Yong Ortemann-Renon, Catherine Kumar, Monica Orphanet J Rare Dis Correction BioMed Central 2023-03-14 /pmc/articles/PMC10012553/ /pubmed/36918897 http://dx.doi.org/10.1186/s13023-023-02647-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Diaz, George A. Giugliani, Roberto Gufon, Nathalie Jones, Simon A. Mengel, Eugen Scarpa, Maurizio Witters, Peter Yarramaneni, Abhimanyu Li, Jing Armstrong, Nicole M. Kim, Yong Ortemann-Renon, Catherine Kumar, Monica Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title | Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title_full | Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title_fullStr | Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title_full_unstemmed | Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title_short | Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| title_sort | correction : long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012553/ https://www.ncbi.nlm.nih.gov/pubmed/36918897 http://dx.doi.org/10.1186/s13023-023-02647-z |
| work_keys_str_mv | AT diazgeorgea correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT giuglianiroberto correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT gufonnathalie correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT jonessimona correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT mengeleugen correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT scarpamaurizio correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT witterspeter correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT yarramaneniabhimanyu correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT lijing correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT armstrongnicolem correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT kimyong correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT ortemannrenoncatherine correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults AT kumarmonica correctionlongtermsafetyandclinicaloutcomesofolipudasealfaenzymereplacementtherapyinpediatricpatientswithacidsphingomyelinasedeficiencytwoyearresults |